Skip to main content
. 2024 Jan 8;11:1326258. doi: 10.3389/fpubh.2023.1326258

Table 1.

Baseline characteristics of the study population in NHANES during the period 2007–2016.

Variables Non-asthma (n = 11,500) Asthma (n = 2081) p-value
Age (years), Median (Q1–Q3) 36.0 (15–57) 29.0 (14–52) <0.001
Gender (n), % 0.056
Man 5,816 (50.6%) 1,005 (48.3%)
Woman 5,684 (49.4%) 1,076 (51.7%)
BMI (Kg/m2), Mean ± SD 26.1 ± 7.3 27.5 ± 8.6 <0.001
PIR (Ratio), Mean ± SD 2.3 ± 1.6 2.2 ± 1.6 <0.001
Race (n), % <0.001
Mexican American 2,210 (19.2%) 247 (11.9%)
Other Hispanic 1,259 (10.9%) 238 (11.4%)
Non-Hispanic white 4,186 (36.4%) 830 (39.9%)
Non-Hispanic Black 2,485 (21.6%) 539 (25.9%)
Other Races 1,360 (11.8%) 227 (10.9%)
Education (n), % <0.001
<9th Grade 958 (8.3%) 94 (4.5%)
9–11th Grade 1,127 (9.8%) 182 (8.7%)
High School Grade 1742 (15.1%) 296 (14.2%)
College 2,173 (18.9%) 443 (21.3%)
≥College Graduate 1791 (15.6%) 269 (12.9%)
Do not know 3,709 (32.3%) 797 (38.3%)
Marital status, N (%) <0.001
Married 4,119 (35.8%) 556 (26.7%)
Widowed 625 (5.4%) 92 (4.4%)
Divorced 782 (6.8%) 180 (8.6%)
Separated 248 (2.2%) 43 (2.1%)
Never married 1,371 (11.9%) 306 (14.7%)
Living with partner 648 (5.6%) 107 (5.1%)
Do not know 3,707 (32.2%) 797 (38.3%)
Diabetes, N (%) <0.001
Yes 960 (8.3%) 230 (11.1%)
No 10,348 (90.0%) 1812 (87.1%)
Border line 188 (1.6%) 37 (1.8%)
Do not know 4 (0.0%) 2 (0.1%)
Hypertension, N (%) <0.001
Yes 2,743 (23.9%) 554 (26.6%)
No 5,861 (51.0%) 903 (43.4%)
Do not know 2,896 (25.2%) 624 (30.0%)
Liver Disease, N (%) <0.001
Yes 278 (2.4%) 82 (3.9%)
No 7,502 (65.2%) 1,199 (57.6%)
Do not know 3,720 (32.3%) 800 (38.4%)
Smoking, N (%) <0.001
Yes 3,401 (29.6%) 682 (32.8%)
No 4,554 (39.6%) 636 (30.6%)
Do not know 3,545 (30.8%) 763 (36.7%)
Alcohol use, N (%) <0.001
Yes 5,124 (44.6%) 920 (44.2%)
No 2,138 (18.6%) 324 (15.6%)
Do not know 4,238 (36.9%) 837 (40.2%)
Blood test, Mean ± SD
TP (g/dL) 7.2 ± 0.5 7.1 ± 0.5 <0.001
Albumin (g/dL) 4.3 ± 0.3 4.3 ± 0.3 <0.001
Globulin (g/dL) 2.9 ± 0.5 2.9 ± 0.5 0.049
ALT (U/L) 24.6 ± 18.4 24.2 ± 15.9 0.47
AST (U/L) 25.7 ± 16.1 25.5 ± 12.9 0.603
BUN (mg/dL) 13.0 ± 5.5 12.5 ± 5.4 <0.001
Scr (mg/dL) 0.9 ± 0.3 0.9 ± 0.3 0.361
TB (mg/dL) 0.7 ± 0.3 0.7 ± 0.3 <0.001
SUA (mg/dL) 5.4 ± 1.4 5.4 ± 1.4 0.141
GFR (mL/min/1.73 m2) 98.3 ± 26.9 100.6 ± 27.3 0.002
Urine metals, Mean ± SD
LnBa (μg/L) 0.2 ± 1.0 0.2 ± 1.0 0.032
LnCd (μg/L) −1.9 ± 1.1 −2.0 ± 1.1 0.008
LnCo (μg/L) −1.0 ± 0.8 −0.9 ± 0.8 <0.001
LnCs (μg/L) 1.4 ± 0.7 1.4 ± 0.7 0.852
LnMo (μg/L) 3.8 ± 0.9 3.8 ± 0.9 0.112
LnPb (μg/L) −0.9 ± 0.9 −1.0 ± 0.9 0.002
LnSb (μg/L) −2.9 ± 0.8 −2.8 ± 0.8 0.003
LnTl (μg/L) −1.9 ± 0.7 −1.9 ± 0.7 0.039
LnTu (μg/L) −2.5 ± 1.1 −2.4 ± 1.1 <0.001
LnHg (ng/mL) −1.2 ± 1.1 −1.3 ± 1.0 0.039
LnU (ug/L) −5.1 ± 1.0 −5.0 ± 1.0 <0.001

NHANES, National Health and Nutrition Examination Survey; SD, standard deviation; BMI, body mass index; PIR, poverty to income ratio; TP, total protein; ALT, alanine aminotransferase; AST, aspartate aminotransferase; BUN, blood urea nitrogen; Scr, serum creatinine; TB, total bilirubin; SUA, serum uric acid; GFR, glomerular filtration rate; Ba, barium; Cd, cadmium; Co, cobalt; Cs, cesium; Mo, molybdenum; Pb, lead; Sb, stibium; Tl, thallium; Tu, tungsten; Hg, mercury; U, uranium.